Demonstrate that the sequential use of rapid CYP2C19 genetic testing and bedside platelet function testing in ACS patients may optimize P2Y12 inhibition treatment.
To evaluate the utility of a new definition of contrast-induced nephropathy, based on creatinine clearance and biomarkers, to identify patients at high risk of mortality in the occurrence of CIN in pa...
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel before coronary angioplasty in subjects treated long term with dual antiplatelet therapy
National, multicentric, trial aiming to evaluate the impact of prasugrel, new platelet inhibitor, in comparison with a loading dose of 900mg clopidogrel and a care dosis of 150mg.
